Merck researcher Max Tishler
Executive Summary
Former President of MS&D Labs Max Tishler, PhD, died March 18. At MS&D, he was the leader of research programs that developed drugs for heart disease, hypertension, arthritis, mental depression and infectious diseases. Tishler "established the pattern for biomedical research at Merck," the firm said in a release. Merck noted that Tishler led the Merck group that developed a production process for penicillin. The researcher was also an emeritus University Professor of the Sciences at Wesleyan University. In recognition of his contributions, Tishler was awarded the National Medal of Science in June 1987.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.